NEUROSENSE THERAPEUTICS LTD. WARRANT reports a Return on Equity (ROE) of 713.14%.

What is NRSNW's dividend yield?

NEUROSENSE THERAPEUTICS LTD. WARRANT offers a dividend yield of 0.00%.

What is NRSNW's Deepscope Quality Score?

Deepscope rates NRSNW's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NRSNW?

Deepscope's AI Timing Score for NRSNW is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Cổ phiếu NRSNW (NASDAQ) | NEUROSENSE THERAPEUTICS LTD. WARRANT

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-09 | FS: 2025-12-31)

NRSNW

NEUROSENSE THERAPEUTICS LTD. WARRANT

US:NASDAQ STOCK News 97

USD 0.15

-0.00 (-0.07%) Day Change

Watchlist Portfolio Compare Chart

-0.06

D/E

713.1%

ROE

-1,082.2%

ROA

0.00%

Div Yield

Data partially updated

NEUROSENSE THERAPEUTICS LTD. WARRANT
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.15 Price -0.00 (-0.07%) Day Change	NEWS SCORE: 97

NRSNW Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) và Thời điểm mua ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
ROA quá thấp so với ROE
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	97
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.15
PBV / Sector	-3.03 / N/A
Earning Per Share	-0.44

PE / Sector	N/A / N/A
PEG or PE/Growth / Sector	N/A / N/A
Average 1M Daily Value	380.011935000000
Average 1W Daily Value	713.616040000000

Yếu tố Kỹ thuật

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / N/A
NPM Average (%) / Sector	N/A / N/A
NPM Change Average (%) / Sector	N/A / N/A
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-1,082.20 / N/A
ROA Average (%) / Sector	-445.69 / N/A
ROA Change Average (%) / Sector	151.17 / N/A GREAT
ROE (%) / Sector	713.14 / N/A GREAT
ROE Average (%) / Sector	168.21 / N/A GREAT
ROE Change Average (%) / Sector	-270.28 / N/A
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / N/A
Dividend Average (%) / Sector	N/A / N/A
Dividend Change Average (%) / Sector	N/A / N/A

Chi tiết đăng ký

Analyze Date	2026-06-10 09:43:46
Symbol	NRSNW
Name	NEUROSENSE THERAPEUTICS LTD. WARRANT
Sector
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	4.72 / N/A

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Building B, Herzliya, Israel, 4672562

Phone: 972 9 799 6183

Website: https://www.neurosense-tx.com

Sector: -

Description: NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.